^™middle.

Gathering signals...

Healius (ASX:HLS) — Material Events

ASX:HLS · 5 articles in the last 12 months · 100% assessed

Click a band to jump to that tier

Major ≥90 Significant 75–89 Notable 50–74 Routine <50 Not assessed

Significant Score 75–89

4

Healius Advances with 3.8% Revenue Growth and Digital Transformation MilestoneMedium

Healius posts 3.8% revenue growth and margin improvement in 1H26, completes digital transformation

18 Feb 2026 ·Half Year Results ·85

Healius Reports 2.2% Revenue Growth Amid $332 Million Goodwill ImpairmentMedium

Healius reports 2026 revenue growth, large goodwill impairment, and ongoing digital transformation

19 Aug 2026 ·Preliminary Final Report ·Unexpected ·80

Healius Secures $60M Pathology Contract with Australian Defence ForceMedium

Healius wins $60M five-year Australian Defence Force pathology services contract

1 Dec 2025 ·Major Contract Announcement ·80

Healius Eyes Agilex Sale Amid Rising Pathology Costs and Budget FreezeMedium

Healius updates FY 2026 outlook, plans Agilex Biolabs sale amid rising pathology costs and no Federal funding

13 May 2026 ·Trading Update ·75

Notable Score 50–74

1

Healius Locks In $45 Million Pathology Deal with Ramsay Health CareMedium

Healius secures national pathology agreement with Ramsay Health Care subsidiaries worth $45 million annually

26 June 2026 ·Major Contract Announcement ·70

Not Assessed Low Score, or missing data

0

No articles in this tier for the last 12 months.

Market Mentions 3 - appeared in market wrap coverage

These are market wrap articles where Healius (ASX:HLS) was mentioned. They reflect broader market coverage, not company-specific announcements.

Healthcare Wrap - Week 34 (17 Aug -> 21 Aug) 2026

Healthcare Wrap - Week 26 (22 June -> 26 June) 2026

Healthcare Wrap - Week 8 (16 Feb -> 20 Feb) 2026